Gabapentin Online

How and where to order Gabapentin (Neurontin) 100 mg, 300 mg, 400 mg, 600 mg, 800 mg capsules or tablets online on Neurointerventions website:

Prices:from $0.45 per pill
Discount:10% coupon: DFHDCC
Forms:100 mg, 300 mg, 400 mg, 600 mg, 800 mg tablets or capsules
Quantity:30-360 pills
Type:Gabapentin brand, Neurontin generic
Payment:Visa, Mastercard, AmEx, E-Check (ACH), Bitcoin
Delivery:Regular airmail and express courier
Shipping:Worldwide, including USA, UK, Europe, Canada, Australia

Gabapentin (trade names include Neurontin, CO Gabapentin, Gabagamma, Gabapentin Actavis, Gabalept, Gabamox, Gabapentin Aurobindo, Gabexal, Gabictal, Gabapentin Hexal, Gabix, Gabapentin Ratiopharm, Vultin, Gabapentin Sandoz, Gabapentin Teva, Gabapentina Cinfa, Gabapentine EG, Gralise, Mylan-Gabapentin, Neurostil, Normatol, Novo-Gabapentin, Nupentin, PMS-Gabapentin, Tebantin, Teva-Gabapentin) is a medication from antiepileptics (anticonvulsants) pharmacological group. This medicine is effective in helping to control focal seizures, partial seizures (convulsions) in patients with epilepsy. It is also used to help relieve certain types of nerve pain, neuropathic pain caused by diabetic neuropathy, peripheral neuropathy, small fiber neuropathy, postherpetic neuralgia, occipital neuralgia, pudendal neuralgia, central pain, and for other nervous system disorders. Gabapentin is widely prescribed off-label for the treatment of non-neuropathic pain, fibromyalgia, erythromelalgia, bipolar disorder, anxiety disorders, restless legs syndrome, essential or orthostatic tremor, burning mouth syndrome, carpal tunnel syndrome, cluster-tic syndrome, cough, hiccups, chemotherapy induced nausea and vomiting, hyperhidrosis, pruritus, reflex sympathetic dystrophy syndrome, spondylolisthesis, syringomyelia, transverse myelitis, trigeminal neuralgia, vulvodynia, Lhermitte's sign, migraine, periodic limb movement disorder, insomnia, sleep disorder in patients with medical illness, for reducing the symptoms of alcohol withdrawal and associated craving; as a first-line treatment of the acquired pendular nystagmus, torsional nystagmus, infantile nystagmus, postmenopausal symptoms, to decrease the frequency of hot flashes in both menopausal women and patients with breast cancer; to reduces spasticity in multiple sclerosis, to alleviate itching in kidney failure (uremic pruritus) and itching of other causes; in veterinary medicine. In recreational purposes in rather high doses gabapentin can induce euphoria, a sense of calm, a marijuana-like high, improved sociability, and reduced alcohol or cocaine cravings.

Neurontin (Gabapentin) logo

Related medications:

  • Armodafinil (Nuvigil, Waklert)
  • Beclamide (Nydrane)
  • Carbamazepine (Tegretol)
  • Carisbamate (Comfyde)
  • Didanosine (Videx)
  • Divalproex (Depakote)
  • Felbamate (Taloxa)
  • Lacosamide (Vimpat)
  • Lamotrigine (Lamictal)
  • Levetiracetam (Keppra)
  • Oxcarbazepine (Trileptal)
  • Perampanel (Fycompa)
  • Phenacemide (Phenurone)
  • Pheneturide (Benuride)
  • Phenytoin (Dilantin)
  • Pregabalin (Lyrica)
  • Primidone (Mysoline)
  • Retigabine (Trobalt)
  • Stiripentol (Diacomit)
  • Sulthiame (Ospolot)
  • Topiramate (Topamax)
  • Zonisamide (Zonegran)

    Pharmacological and medical categories:

  • Anticonvulsants
  • Antiepileptic agents
  • Drugs for neuropathic pain
  • Gamma-aminobutyric acid analogs
  • Nootropics and neurotonics
  • Pain relief medications
  • Veterinary, pet meds

    ATC codes:

  • N - Nervous system
  • N03 - Antiepileptics
  • N03A - Antiepileptics
  • N03AX - Other antiepileptics
  • N03AX12 - Gabapentin

    ICD-10 codes:

  • Zoster [herpes zoster] - B02
  • Postherpetic polyneuropathy - B02.23
  • Malignant neoplasm of breast - C50
  • Type 2 diabetes mellitus - E11
  • Type 2 diabetes mellitus with diabetic neuropathy, unspecified - E11.40
  • Alcohol related disorders - F10
  • Alcohol dependence with withdrawal - F10.23
  • Bipolar disorder - F31
  • Anxiety, dissociative, stress-related, somatoform and other nonpsychotic mental disorders - F40-F48
  • Other extrapyramidal and movement disorders - G25
  • Essential tremor - G25.0
  • Other specified forms of tremor - G25.2
  • Restless legs syndrome - G25.81
  • Multiple sclerosis - G35
  • Other demyelinating diseases of central nervous system - G37
  • Acute transverse myelitis in demyelinating disease of central nervous system - G37.3
  • Epilepsy and recurrent seizures - G40
  • Migraine - G43
  • Other headache syndromes - G44
  • Cluster headache syndrome, unspecified - G44.00
  • Sleep disorders - G47
  • Insomnia - G47.0
  • Periodic limb movement disorder - G47.61
  • Disorders of trigeminal nerve - G50
  • Trigeminal neuralgia - G50.0
  • Mononeuropathies of upper limb - G56
  • Carpal tunnel syndrome - G56.0
  • Other mononeuropathies - G58
  • Other specified mononeuropathies - G58.8
  • Hereditary and idiopathic neuropathy - G60
  • Other hereditary and idiopathic neuropathies - G60.8
  • Hemiplegia and hemiparesis - G81
  • Pain, not elsewhere classified - G89
  • Central pain syndrome - G89.0
  • Disorders of autonomic nervous system - G90
  • Complex regional pain syndrome I (CRPS I) - G90.5
  • Other idiopathic peripheral autonomic neuropathy - G90.09
  • Other and unspecified diseases of spinal cord - G95
  • Syringomyelia and syringobulbia - G95.0
  • Nystagmus and other irregular eye movements - H55
  • Unspecified nystagmus - H55.00
  • Other forms of nystagmus - H55.09
  • Other peripheral vascular diseases - I73
  • Erythromelalgia - I73.81
  • Diseases of tongue - K14
  • Glossodynia - K14.6
  • Pruritus - L29
  • Other pruritus - L29.8
  • Other deforming dorsopathies - M43
  • Spondylolisthesis - M43.1
  • Dorsalgia - M54
  • Occipital neuralgia - M54.81
  • Other soft tissue disorders, not elsewhere classified - M79
  • Neuralgia and neuritis, unspecified - M79.2
  • Fibromyalgia - M79.7
  • Pain and other conditions associated with female genital organs and menstrual cycle - N94
  • Vulvodynia - N94.81
  • Menopausal and other perimenopausal disorders - N95
  • Menopausal and female climacteric states - N95.1
  • Cough - R05
  • Abnormalities of breathing - R06
  • Hiccough - R06.6
  • Nausea and vomiting - R11
  • Other symptoms and signs involving the nervous and musculoskeletal systems - R29
  • Other symptoms and signs involving the nervous system - R29.818
  • Pain, not elsewhere classified - R52
  • Generalized hyperhidrosis - R61

    Indications and usage:

    Neurontin (Gabapentin) is indicated for:

  • Postherpetic neuralgia in adults.
  • Adjunctive therapy in the treatment of partial onset seizures, with and without secondary generalization, in adults and pediatric patients 3 years and older with epilepsy.

    Dosage and administration:

    Postherpetic neuralgia

  • Dose can be titrated up as needed to a dose of 1800 mg/day.
  • Day 1: Single 300 mg dose.
  • Day 2: 600 mg/day (i.e., 300 mg two times a day).
  • Day 3: 900 mg/day (i.e., 300 mg three times a day).

    Epilepsy with partial onset seizures

  • Patients 12 years of age and older: starting dose of gabapentin is 300 mg three times daily; may be titrated up to 600 mg three times daily.
  • Patients 3 to 11 years of age: starting dose range is 10 to 15 mg/kg/day, given in three divided doses; recommended dose in patients 3 to 4 years of age is 40 mg/kg/day, given in three divided doses; the recommended dose in patients 5 to 11 years of age is 25 to 35 mg/kg/day, given in three divided doses. The recommended dose is reached by upward titration over a period of approximately 3 days.

    Gabapentin dose should be adjusted in patients with reduced renal function.

    Dosage forms and strengths:

  • Neurontin (Gabapentin) capsules: 100 mg, 300 mg, and 400 mg.
  • Neurontin (Gabapentin) tablets: 600 mg, and 800 mg.
  • Neurontin (Gabapentin) oral solution: 250 mg / 5 ml.


    Signs of acute toxicity in animals included ataxia, labored breathing, ptosis, sedation, hypoactivity, or excitation.

    Acute oral overdoses of gabapentin have been reported. Symptoms have included double vision, tremor, slurred speech, drowsiness, altered mental status, dizziness, lethargy, and diarrhea. Fatal respiratory depression has been reported with Neurontin overdose, alone and in combination with other CNS depressants.

    Gabapentin can be removed by hemodialysis.


    Known hypersensitivity to gabapentin or ingredients of its pharmaceutical forms.

    Warnings and precautions:

  • Drug reaction with eosinophilia and systemic symptoms (multiorgan hypersensitivity): discontinue gabapentin if alternative etiology is not established.
  • anaphylaxis and angioedema: discontinue and evaluate patient immediately.
  • Driving impairment; somnolence/sedation and dizziness: warn patients not to drive until they have gained sufficient experience to assess whether their ability to drive or operate heavy machinery will be impaired.
  • Increased seizure frequency may occur in patients with seizure disorders if Neurontin is abruptly discontinued.
  • Suicidal behavior and ideation: monitor for suicidal thoughts/behavior.
  • Respiratory depression: may occur with Gabapentin (Neurontin) when used with concomitant central nervous system (CNS) depressants, including opioids, or in the setting of underlying respiratory impairment. Monitor patients and adjust dosage as appropriate.
  • Neuropsychiatric adverse reactions in children 3 to 12 years of age: monitor for such events.

    Side effects, adverse reactions:

    Most common adverse reactions of gabapentin (incidence >= 8% and at least twice that for placebo) were:

  • Postherpetic neuralgia: dizziness, somnolence, and peripheral edema.
  • Epilepsy in patients > 12 years of age: somnolence, dizziness, ataxia, fatigue, and nystagmus.
  • Epilepsy in patients 3 to 12 years of age: viral infection, fever, nausea and/or vomiting, somnolence, and hostility.

    To report suspected adverse reactions, contact Pfizer Inc. or your local FDA.

    Drug interactions:

    Concentrations increased by morphine; may need dose adjustment.

    Use in specific populations:


    Based on animal data, may cause fetal harm.

    Patient counseling information:

    Administration information

    Inform patients that Neurontin (Gabapentin) is taken orally with or without food. Inform patients that, should they divide the scored 600 mg or 800 mg tablet in order to administer a half-tablet, they should take the unused half-tablet as the next dose. Advise patients to discard half-tablets not used within 28 days of dividing the scored tablet.

    Drug reaction with eosinophilia and systemic symptoms (DRESS)/multiorgan hypersensitivity

    Prior to initiation of treatment with gabapentin, instruct patients that a rash or other signs or symptoms of hypersensitivity (such as fever or lymphadenopathy) may herald a serious medical event and that the patient should report any such occurrence to a physician immediately.

    Anaphylaxis and angioedema

    Advise patients to discontinue Neurontin and seek medical care if they develop signs or symptoms of anaphylaxis or angioedema.

    Dizziness and somnolence and effects on driving and operating heavy machinery

    Advise patients that Gabapentin (Neurontin) may cause dizziness, somnolence, and other symptoms and signs of CNS depression. Other drugs with sedative properties may increase these symptoms. Accordingly, although patients' ability to determine their level of impairment can be unreliable, advise them neither to drive a car nor to operate other complex machinery until they have gained sufficient experience on Neurontin to gauge whether or not it affects their mental and/or motor performance adversely. Inform patients that it is not known how long this effect lasts.

    Suicidal thinking and behavior

    Counsel the patient, their caregivers, and families that AEDs, including gabapentin, may increase the risk of suicidal thoughts and behavior. Advise patients of the need to be alert for the emergence or worsening of symptoms of depression, any unusual changes in mood or behavior, or the emergence of suicidal thoughts, behavior, or thoughts about self-harm. Instruct patients to report behaviors of concern immediately to healthcare providers.

    Respiratory depression

    Inform patients about the risk of respiratory depression. Include information that the risk is greatest for those using concomitant CNS depressants (such as opioid analgesics) or those with underlying respiratory impairment. Teach patients how to recognize respiratory depression and advise them to seek medical attention immediately if it occurs.

    Use in pregnancy

    Instruct patients to notify their physician if they become pregnant or intend to become pregnant during therapy, and to notify their physician if they are breast feeding or intend to breast feed during therapy.

    Encourage patients to enroll in the NAAED Pregnancy Registry if they become pregnant. This registry is collecting information about the safety of antiepileptic drugs during pregnancy.

    Pregnancy categories:

  • B1 - Australia
  • C - United States (Risk cannot be ruled out)

    Salts and other forms:

  • Gabapentin Base
  • Gabapentin Enacarbil
  • Gabapentin Hydrochloride

    Synonyms, international and chemical names:

  • 1-(Aminomethyl)Cyclohexaneacetic Acid
  • Cyclohexaneacetic Acid, 1-(Aminomethyl)-
  • Gabapentina
  • Gabapentine
  • Gabapentino
  • Gabapentinum
  • Gabapentyna

    Brands, generics, trade names:

  • Apo-Gabapentin - Apotex, Hind Wing, Pharmaforte
  • Blugat - Landsteiner Scientific
  • CO Gabapentin - Cobalt Pharmaceuticals
  • Dineurin - Drugtech Laboratorio, Recalcine Laboratorios
  • Gabagamma - Worwag Pharma, Artesan Pharma
  • Gabalept - Micro Labs, Brown & Burk Pharmaceuticals, Synapse Medical
  • Gabamox - Pentafarma
  • Gabaneurin - EMS Industria Farmaceutica
  • Gabapentin - Accord Healthcare, Actavis, Aurobindo, Hexal, Mepha, Mylan, Ratiopharm, Sandoz, Teva
  • Gabapentina - Cinfa Laboratorios, Generis Farmaceutica, Normon Laboratorios, Pfizer, Stada, Teva
  • Gabapentine - Arrow Generiques, Biogaran, EG Labo, Mylan, Sandoz, Sanofi-Aventis, Teva, Zentiva
  • Gabapin-SR - Intas Pharmaceuticals
  • Gabastar - Lupin Laboratories
  • Gabatal - F. Joh. Kwizda
  • GabaTeva - Teva, Med Ilac
  • Gabator - Torrent Pharmaceuticals
  • Gabatrex - Intas Pharmaceuticals, Singapore Genebio
  • Gabatur - Cantabria Industrial Farmaceutica
  • Gabexal - Sandoz, Hexal
  • Gabictal - Tecnofarma
  • Gabix - Getz Pharma
  • Gafen - Siegfried Laboratorios
  • Gapridol - Psicofarma Laboratorio
  • Gralise - Abbott, Depomed
  • Logistic - Craveri
  • Mylan-Gabapentin - Mylan
  • Neogab - Hilton Pharma
  • Neurontin - Pfizer, Parke-Davis
  • Neurostil - IVAX
  • Nopatic - Rayere Farmaceuticos
  • Normatol - Pfizer
  • Novo-Gabapentin - Novopharm
  • Nupentin - Alphapharm, Merck, Ranbaxy, Serono
  • Nyepzyl - Ultra Laboratorios
  • PMS-Gabapentin - Pharmascience, IDS Group, Pharmaniaga, Ranbaxy
  • Pro-Gabapentin - Pro Doc
  • Ran-Gabapentin - Ranbaxy
  • Regalden - Mavi Farmaceutica
  • Ritmenal - Instituto Sanitas
  • Rontin - Biolab, Biopharm Chemicals
  • Tebantin - Gedeon Richter
  • Teva-Gabapentin - Teva
  • Ultraneural - Raffo Laboratorios
  • Vultin - Unison Laboratories, Medline

    APIs used in medicine in combinations with gabapentin:

  • Alpha-Lipoic Acid
  • Amitriptyline
  • Folic Acid
  • Lipoic Acid
  • Meloxicam
  • Methylcobalamin (Vitamin B12)
  • Nortriptyline
  • Vitamin B6 (Pyridoxine Hydrochloride)

    Here is a list of popular medications containing gabapentin as a main active pharmaceutical ingredient; their trade names, forms, doses, companies - manufacturers, distributors, suppliers, researchers and developers:

    Trade name of the drug Pharmaceutical forms and doses Companies
  • Capsules; Oral; Gabapentin 100 mg
  • Capsules; Oral; Gabapentin 300 mg
  • Capsules; Oral; Gabapentin 400 mg
  • Worwag Pharma
  • Artesan Pharma
  • Gabalept
  • Capsules; Oral; Gabapentin 100 mg
  • Capsules; Oral; Gabapentin 300 mg
  • Capsules; Oral; Gabapentin 400 mg
  • Tablets; Oral; Gabapentin 100 mg
  • Tablets; Oral; Gabapentin 300 mg
  • Tablets; Oral; Gabapentin 400 mg
  • Micro Labs
  • Brown & Burk Pharmaceuticals
  • Synapse Medical
  • Gabix
  • Capsules; Oral; Gabapentin 100 mg
  • Capsules; Oral; Gabapentin 300 mg
  • Capsules; Oral; Gabapentin 400 mg
  • Tablets; Oral; Gabapentin 600 mg
  • Getz Pharma
  • Gralise
  • Tablets, Film-Coated; Oral; Gabapentin 300 mg
  • Tablets, Film-Coated; Oral; Gabapentin 600 mg
  • Abbott
  • Depomed
  • Mylan-Gabapentin
  • Capsules; Oral; Gabapentin 100 mg
  • Capsules; Oral; Gabapentin 300 mg
  • Capsules; Oral; Gabapentin 400 mg
  • Tablets; Oral; Gabapentin 600 mg
  • Tablets; Oral; Gabapentin 800 mg
  • Mylan
  • Neurontin
  • Capsules; Oral; Gabapentin 100 mg
  • Capsules; Oral; Gabapentin 300 mg
  • Capsules; Oral; Gabapentin 400 mg
  • Capsules; Oral; Gabapentin 800 mg
  • Solution; Oral; Gabapentin 250 mg / 5 ml
  • Tablets, Film-Coated; Oral; Gabapentin 600 mg
  • Tablets, Film-Coated; Oral; Gabapentin 800 mg
  • Tablets; Oral; Gabapentin 600 mg
  • Tablets; Oral; Gabapentin 800 mg
  • Pfizer
  • Maxxcare
  • Parke-Davis
  • Zuellig Pharma
  • Nupentin
  • Capsules; Oral; Gabapentin 100 mg
  • Capsules; Oral; Gabapentin 300 mg
  • Capsules; Oral; Gabapentin 400 mg
  • Alphapharm
  • Merck
  • Ranbaxy
  • Serono
  • Zuellig Pharma
  • Teva-Gabapentin
  • Capsules; Oral; Gabapentin 100 mg
  • Capsules; Oral; Gabapentin 300 mg
  • Capsules; Oral; Gabapentin 400 mg
  • Tablets, Film-Coated; Oral; Gabapentin 600 mg
  • Tablets, Film-Coated; Oral; Gabapentin 800 mg
  • Teva

  • References:

  • Gabapentin main article on Wikipedia:
  • Gabapentin compound on PubChem:
  • Gabapentin medicine on DrugBank:
  • Gabapentin FAQ on MedlinePlus (revised 05/15/2020):
  • Gabapentin Ranbaxy capsules drug label on DailyMed (revised March 3, 2014):
  • Neurontin (Gabapentin) capsules, film-coated tablets, solution drug label on DailyMed (revised December 28, 2020):
  • Gabapentin containing drugs on
  • Gabapentin for sale on Pharma Doctor:
  • Gabapentin international drug names on
  • Neurontin (Gabapentin) capsules, tablets, solution for oral use official prescribing information and medication guide from the U.S. FDA (revised 10/2017):
  • Neurontin (Gabapentin) capsules, tablets, solution for oral use prescribing information and medication guide from Pfizer pharmaceutical company (revised 12/2020):
  • Neurontin (Gabapentin) 100 mg, 300 mg, 400 mg, 600 mg, 800 mg capsules consumer medicine information from MedSafe (revised December 2020):
  • Nupentin (Gabapentin) capsules product information from The Therapeutic Goods Administration (revised 06/08/2019):
  • Gralise (Gabapentin) tablets official website:
  • Neurontin (Gabapentin) 100 mg, 300 mg, 400 mg hard capsules, 600 mg and 800 mg film-coated tablets patient information leaflet from (revised 05/2020):

    Revised: June 2021